Board Meeting27 Jul 2026, 06:20 pm
Oxygenta Pharma Declares Un-audited Q1 FY27 Results
AI Summary
Oxygenta Pharmaceutical Ltd announced its un-audited financial results for the quarter ended June 30, 2026. The Board of Directors also approved the appointment of M/s. PCR & Associates as Cost Auditors for FY 2026-27 and scheduled the Annual General Meeting for August 21, 2026. The POSH Committee of the Board was re-constituted.
Key Highlights
- Board approved un-audited financial results for Q1 FY27.
- Appointed PCR & Associates as Cost Auditors for FY 2026-27.
- AGM scheduled for August 21, 2026, via VC/OAVM.
- Re-constituted the POSH Committee of the Board.
- Limited Review Report for the quarter was also approved.
Price Impact
More from OXYGENTAPH